Historical Stock Price
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| ACER Historical Stock Prices |
| Preferred Stock Newsletter |
| ACER Options Chain |
| Stock Message Boards |
Acer Therapeutics (ACER) has the following price history information. Looking back at ACER historical stock prices for the last five trading days, on March 01, 2021, ACER opened at $3.23, traded as high as $3.29 and as low as $3.11, and closed at $3.25. Trading volume was a total of 148.90K shares. On March 02, 2021, ACER opened at $3.50, traded as high as $3.50 and as low as $3.16, and closed at $3.19. Trading volume was a total of 183.20K shares. On March 03, 2021, ACER opened at $3.29, traded as high as $3.45 and as low as $3.16, and closed at $3.38. Trading volume was a total of 191.80K shares. On March 04, 2021, ACER opened at $3.24, traded as high as $3.40 and as low as $2.75, and closed at $2.85. Trading volume was a total of 450.90K shares. On March 05, 2021, ACER opened at $2.83, traded as high as $2.90 and as low as $2.50, and closed at $2.87. Trading volume was a total of 211.20K shares.
ACER Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acer Therapeutics shares, starting with a $10,000 purchase of ACER, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 03/08/2011 | |
| End date: | 03/05/2021 | |
| Start price/share: | $18.54 | |
| End price/share: | $2.87 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -84.52% | |
| Average Annual Total Return: | -17.02% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $1,547.87 | |
| Years: | 10.00 | |
 | |||||
| ACER Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 03/01/2021 | $3.23 | $3.29 | $3.11 | $3.25 | 148.90K |
| 03/02/2021 | $3.50 | $3.50 | $3.16 | $3.19 | 183.20K |
| 03/03/2021 | $3.29 | $3.45 | $3.16 | $3.38 | 191.80K |
| 03/04/2021 | $3.24 | $3.40 | $2.75 | $2.85 | 450.90K |
| 03/05/2021 | $2.83 | $2.90 | $2.50 | $2.87 | 211.20K |
|
| About Acer Therapeutics |
| Acer Therapeutics is a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Co.'s pipeline includes three clinical-stage candidates: EDSIVO™ (celiprolol) for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001 (a taste-masked, immediate release formulation of sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders and Maple Syrup Urine Disease; and osanetant for the treatment of induced Vasomotor Symptoms where Hormone Replacement Therapy is likely contraindicated. |
| ACER Historical Closing Prices | |
| Date | Close |
| 03/01/2021 | $3.25 |
| 03/02/2021 | $3.19 |
| 03/03/2021 | $3.38 |
| 03/04/2021 | $2.85 |
| 03/05/2021 | $2.87 |
| Healthcare Historical Prices |
| ACER is categorized under the Healthcare sector; below are some other companies in the same sector:
ACET Historical Stock Prices Also explore: ACER shares outstanding history |
